ORGO

Organogenesis Holdings Inc.

Price

$1.71

return (12m)

-66.70%

p/e

-2.56

p/bv

1.45

DIVIDEND YIELD

0.00%

ORGO price

Organogenesis Holdings

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ORGO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-29.25%

3 months

-33.66%

1 year

-66.70%

2 years

-41.81%

5 years

-89.30%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ORGO

Valuation

P/E

-2.56

Sector -4.26

Industry -4.26

P/BV

1.45

Sector 2.11

Industry 2.11

P/Revenue (PSR)

0.47

Sector 2.08

Industry 2.08

EV/EBITDA

Sector -546.19

Industry -546.19

EV/EBIT

Sector -37.31

Industry -37.31

P/EBITDA

Sector -50.76

Industry -50.76

P/EBIT

Sector -39.62

Industry -39.62

P/Total Assets

0.53

Sector 1.25

Industry 1.25

P/Net Current Assets

2.63

Sector -5.47

Industry -5.47

P/Working Capital

1.50

Sector -1.10

Industry -1.10

EPS

-0.65

Sector -1.94

Industry -1.94

BVPS

1.15

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

70.35%

Sector 38.90%

Industry 38.90%

EBITDA Margin

0.00%

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

0.00%

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

-7.84%

Sector -36.74%

Industry -36.74%

Net Profit Margins

-18.40%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.11

Sector 0.03

Industry 0.03

Profitability

ROE

-56.76%

Sector -61.50%

Industry -61.50%

ROA

-20.71%

Sector -63.85%

Industry -63.85%

ROIC

0.00%

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.52

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

0.00

Sector -0.60

Industry -0.60

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

0.36

Sector 0.43

Industry 0.43

Liabilities/Assets

0.29

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

-0.46%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals ORGO

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ORGO Organogenesis Holdings Inc.	$1.71	-64.77%	0.00%	-2.56	1.45	-56.76%	-18.40%
JNJ Johnson & Johnson	$266.50	55.29%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$27.87	21.03%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$256.91	27.42%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$45.62	-14.65%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$147.77	82.61%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$161.98	3.71%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.29	45.78%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$76.84	-49.43%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$792.43	37.47%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$432.42	55.55%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$105.00	43.48%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$897.16	31.93%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$542.40	39.41%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$235.19	59.60%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.29	3.26%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$217.24	59.31%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ORGO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Organogenesis Holdings

Organogenesis Holdings Inc.

Average Investor10 user rating

4.0 (1 people)

United States

11 years

Founded: 2015

2016

Time since IPO - 10 years

910

Employees

Organogenesis Holdings Inc. (United States) is listed on the Nasdaq and has a market capitalization of $215.43 million, with shareholders equity totaling $148.27 million.

The company employs approximately 910 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Organogenesis Holdings Inc. reported $457.46 million in revenue, generating net income of $-84.16 million.

Key financial metrics include a P/E ratio of -2.56, a price-to-book (P/B) ratio of 1.45, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ORGO.

Market cap

$215.43 million

Net worth

$148.27 million

$148,270,000.00

Assets

$406.45 million

$406,450,000.00

Total Shares Outstanding

129.00 million

129,000,000

Average Daily Trading Volume

$843.73 Thousand

$843,725.80

Sector

Health Care

Industry

Biotechnology

ORGO

ORGO revenue and profits

Financial Results ORGO

DRAG THE FRAME TO SEE MORE DATA

ORGO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$897.16 31,33% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$235.19 60,10% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$256.91 26,00% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$147.77 82,50% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$161.98 3,46% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$27.87 22,54% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$897.16 31,33% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$235.19 60,10% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$256.91 26,00% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$147.77 82,50% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$161.98 3,46% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$27.87 22,54% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Organogenesis Holdings (ORGO) today?

A cotação de Organogenesis Holdings (ORGO) hoje está em US$ 1.71, com uma variação de -66.7% em relação ao último ano. A cotação de Organogenesis Holdings (ORGO) iniciou o ano negociando na casa dos US$ 5.18 e hoje está em US$ 1.71. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Organogenesis Holdings (ORGO) e dados de ações do Ibovespa e mercados internacionais.

Quando Organogenesis Holdings (ORGO) paga dividendos?

Organogenesis Holdings (ORGO) não distribuiu dividendos no último ano.

Is Organogenesis Holdings (ORGO) a good investment?

Atualmente, Organogenesis Holdings (ORGO) está cotada a US$ 1.71, com um P/L de -2.56, representando um desvio de 12,507% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -66.7 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -66.70%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Organogenesis Holdings (ORGO) stock?

Investir em ações de Organogenesis Holdings (ORGO) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Organogenesis Holdings (ORGO) yield today?

A rentabilidade de Organogenesis Holdings (ORGO) foi de -29.25% no último mês, -66.70% no último ano e -89.30% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Organogenesis Holdings (ORGO) hoje, o investimento total seria de US$ 170.50, com base na cotação atual de US$ 1.71.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 56.78
Em 5 anos: US$ 18.24
Em 10 anos: US$ 170.50

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ORGO

Organogenesis Holdings Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ORGO

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ORGO WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Organogenesis Holdings

Organogenesis Holdings Inc.

United States

11 years

2016

910

PROFIT X PRICE ORGO

Financial Results ORGO

ORGO cash flow

Asset, Revenue and Profit Growth - ORGO

ORGO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions